Clinical Trial Update: RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus [Phase 3]

View source ↗

Summary

Phase 3 randomized trial examining combined modality treatment for esophageal squamous cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Ministry of Scientific Research and Information Technology, Poland | Conditions: Esophageal Neoplasms, Squamous Cell Cancer | Phase 3 | Status: TERMINATED